Read the latest news from regional and global sources, presenting different voices and perspectives.
LEO Pharma's Anzupgo cream receives European marketing approval for adults with moderate to severe chronic hand eczema
Pharmabiz.com
·
LEO Pharma A/S, a global leader in medical dermatology, announced that the European Commission (EC) has granted marketing authorization for Anzupgo (delgocitinib) cream for the treatment of adult patients with moderate to severe chronic hand...
EC authorises LEO Pharma Anzupgo cream for chronic hand eczema
Pharmaceutical Technology
·
September 24, 2024
The European Commission (EC) has granted marketing authorisation to Leo Pharma’s Anzupgo (delgocitinib) cream for treating adults with moderate to severe chronic hand eczema (CHE). The cream is indicated for use in CHE patients for whom topical...
Take Control of Your Cash Flow: Proven Strategies for AR Leaders
CFO Dive
·
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing this on-demand presentation. Oops something went wrong. Watch Now {"LSQLeadFields":[{"Seq":1,"Name":"First...
Dengue, mosquito-borne diseases rising in Europe: EU agency
TerraDaily
·
Dengue, mosquito-borne diseases rising in Europe: EU agency by AFP Staff Writers Stockholm (AFP) June 11, 2024 Cases of dengue and other mosquito-borne diseases are rising significantly in Europe as climate change creates warmer conditions that...
Ivoclar Rebrands Prophy Paste Line and Adds New Flavors
Dentistry Today
·
August 4, 2025
The company announced that its Proxyt prophy paste is being rebranded to VivaDent Polishing Paste. Ivoclar’s trusted Proxyt prophy paste is being rebranded to VivaDent Polishing Paste. Alongside this new brand name, the company has announced 2...
Moldova will be able to purchase batches of vaccines and medicines together with EU countries
MoldovaLive
·
September 20, 2024
Moldova will soon be able to participate in joint public procurement procedures for purchasing medical supplies to address serious health threats. The Parliament’s Commission for Foreign Policy and European Integration has approved the...
Border controls in Portugal
The Portugal News
·
Sometimes when you cross the borders between Portugal and Spain, it isn’t obvious - maybe the tarmac will be different in colour (or quality), or the building styles will change slightly the further you progress either way, and there may be a sign...
EAM Jaishankar wraps up Switzerland visit: Focus on multilateralism, human rights, and traditional medicine
Financial Express
·
External Affairs Minister S. Jaishankar concluded a two-day visit to Switzerland, engaging with top dignitaries and discussing India’s approach to multilateralism, human rights, and the promotion of traditional medicine systems on a global scale....
During Switzerland visit, Jaishankar shares India's approach to multilateralism, discusses ways to promote traditional medicine
Big News Network
·
Geneva [Switzerland], September 14 (ANI): External Affairs Minister S Jaishankar, concluded his two-day visit to Switzerland, during which he interacted with several top dignitaries and shared India's approach to multilateralism, human rights and...
World News | During Switzerland Visit, Jaishankar Shares India's Approach to Multilateralism, Discusses Ways to Promote Traditional Medicine
Latestly
·
September 14, 2024
Geneva [Switzerland], September 14 (ANI): External Affairs Minister S Jaishankar, concluded his two-day visit to Switzerland, during which he interacted with several top dignitaries and shared India's approach to multilateralism, human rights and...
ExCellThera gains EC authorisation for Zemcelpro cell therapy
Pharmaceutical Technology
·
August 28, 2025
ExCellThera has announced that the European Commission (EC) has granted conditional marketing authorisation for its Zemcelpro cell therapy to treat blood cancer patients without access to suitable donor cells. The approval was granted to the...
Zemcelpro Stem Cell Therapy Granted EC Conditional Marketing Authorizaion
BioPharm International
·
Montreal, Canada-based ExCellThera, a company specializing in blood stem cell expansion and metabolic fitness, and its wholly owned subsidiary Cordex Biologics, announced on Aug. 27, 2025 that it has received conditional marketing authorization by...
Horizon - ESG Regulatory News and Trends - August 2025
JD Supra - California
·
August 30, 2025
[co-author: Semhal Gebrekirstos] Welcome to Horizon, DLA Piper’s monthly bulletin reporting on late-breaking legislative and policy developments in ESG. Our aim is to scan the litigation, enforcement, and regulatory horizon to help inform business...
La Unión Europea aprueba una terapia inyectable semestral para la prevención del VIH
Gay Times
·
August 28, 2025
La Comisión Europea (CE) ha aprobado la comercialización de un fármaco inyectable como profilaxis previa a la exposición (PrEP) para reducir el riesgo de transmisión del VIH. El medicamento, un inyectable de administración semestral conocido...
The Digital Shift: Redefining Insurance with Smarter Payments
Banking Dive
·
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing the on-demand presentation. Oops something went wrong. Watch Now {"LSQLeadFields":[{"Seq":1,"Name":"First...
ImmunityBio Wins U.K. Approval
Los Angeles Business Journal - California
·
August 18, 2025
Culver City-based ImmunityBio Inc. has started to take its Anktiva immunotherapy drug global. Last month, the United Kingdom Medicines and Healthcare Products Regulatory Agency approved Anktiva for treatment alongside a bacterial therapy for...
'Battle of infirm not Old Firm as Celtic & Rangers limp into derby'
BBC
·
August 30, 2025
Both clubs are limping into Sunday, but Celtic at least have the comfort of a six-point cushion at the top of the Premiership. They've only had to be half-decent in establishing that lead. They've been okay and nothing more. By contrast, Rangers...
European Commission approves twice-yearly HIV injection lenacapavir, paving way
Mid Day Mumbai
·
August 27, 2025
The European Commission approves lenacapavir, a twice-yearly HIV prevention injection, for rollout across the EU. Sold as Yeytuo, it offers a breakthrough alternative to daily PrEP, addressing rising HIV cases across Europe. The European...
World News | European Commission Approves Twice-yearly HIV Injection Lenacapavir, Paving Way for EU Rollout
Latestly
·
August 27, 2025
Brussels [Belgium], August 27 (ANI): The European Commission has formally approved a twice-yearly injection to prevent HIV, paving the way for its rollout across the European Union, Euro News reported, citing drugmaker Gilead. The new treatment...
European Commission approves twice-yearly HIV injection lenacapavir, paving way for EU rollout
The Tribune (Chandigarh)
·
August 27, 2025
Brussels [Belgium], August 27 (ANI): The European Commission has formally approved a twice-yearly injection to prevent HIV, paving the way for its rollout across the European Union, Euro News reported, citing drugmaker Gilead. The new treatment...